These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 11090546)

  • 21. Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels.
    Arias C; González T; Moreno I; Caballero R; Delpón E; Tamargo J; Valenzuela C
    Cardiovasc Res; 2003 Mar; 57(3):660-9. PubMed ID: 12618228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.
    Ridley JM; Milnes JT; Benest AV; Masters JD; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2003 Jun; 306(2):388-93. PubMed ID: 12804575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human ether-à-go-go-related gene K+ channel gating probed with extracellular ca2+. Evidence for two distinct voltage sensors.
    Johnson JP; Mullins FM; Bennett PB
    J Gen Physiol; 1999 Apr; 113(4):565-80. PubMed ID: 10102937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
    Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
    Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use-dependent 'agonist' effect of azimilide on the HERG channel.
    Jiang M; Dun W; Fan JS; Tseng GN
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1324-36. PubMed ID: 10565858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Na+ permeation and block of hERG potassium channels.
    Gang H; Zhang S
    J Gen Physiol; 2006 Jul; 128(1):55-71. PubMed ID: 16769794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels.
    Yang BF; Xu DH; Xu CQ; Li Z; Du ZM; Wang HZ; Dong DL
    Acta Pharmacol Sin; 2004 May; 25(5):554-60. PubMed ID: 15132818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of deactivation by an amino terminal domain in human ether-à-go-go-related gene potassium channels.
    Wang J; Trudeau MC; Zappia AM; Robertson GA
    J Gen Physiol; 1998 Nov; 112(5):637-47. PubMed ID: 9806971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872.
    Thomas D; Wendt-Nordahl G; Röckl K; Ficker E; Brown AM; Kiehn J
    J Pharmacol Exp Ther; 2001 May; 297(2):753-61. PubMed ID: 11303067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency.
    Ishii K; Nagai M; Takahashi M; Endoh M
    Cardiovasc Res; 2003 Mar; 57(3):651-9. PubMed ID: 12618227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic control of deactivation gating by a soluble amino-terminal domain in HERG K(+) channels.
    Wang J; Myers CD; Robertson GA
    J Gen Physiol; 2000 Jun; 115(6):749-58. PubMed ID: 10828248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered gating of HERG potassium channels by cobalt and lanthanum.
    Sanchez-Chapula JA; Sanguinetti MC
    Pflugers Arch; 2000 Jun; 440(2):264-74. PubMed ID: 10898527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Block of HERG current expressed in HEK293 cells by the Na+-channel blocker cibenzoline.
    Hiramatsu M; Wu LM; Hirano Y; Kawano S; Furukawa T; Hiraoka M
    Heart Vessels; 2004 May; 19(3):137-43. PubMed ID: 15168062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of HERG K+ currents by Cd2+ destabilization of the inactivated state.
    Johnson JP; Balser JR; Bennett PB
    Biophys J; 1999 Nov; 77(5):2534-41. PubMed ID: 10545354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High affinity HERG K(+) channel blockade by the antiarrhythmic agent dronedarone: resistance to mutations of the S6 residues Y652 and F656.
    Ridley JM; Milnes JT; Witchel HJ; Hancox JC
    Biochem Biophys Res Commun; 2004 Dec; 325(3):883-91. PubMed ID: 15541373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
    Sanguinetti MC; Jiang C; Curran ME; Keating MT
    Cell; 1995 Apr; 81(2):299-307. PubMed ID: 7736582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Block of wild-type and inactivation-deficient human ether-a-go-go-related gene K+ channels by halofantrine.
    Sánchez-Chapula JA; Navarro-Polanco RA; Sanguinetti MC
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Dec; 370(6):484-91. PubMed ID: 15558243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine.
    Scholz EP; Zitron E; Kiesecker C; Lueck S; Kathöfer S; Thomas D; Weretka S; Peth S; Kreye VA; Schoels W; Katus HA; Kiehn J; Karle CA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):404-14. PubMed ID: 14557918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
    Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular determinants of cocaine block of human ether-á-go-go-related gene potassium channels.
    Guo J; Gang H; Zhang S
    J Pharmacol Exp Ther; 2006 May; 317(2):865-74. PubMed ID: 16397089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.